Search research articles
Contact Us
Filters
Showing results (1-10 of 7) with videos related to
Page
of 1
Sort By:
The Canadian Journal of Hospital Pharmacy
|
August 9, 1980
Developing an adverse drug reaction program in nursing homes
J A Soon
The Canadian Journal of Hospital Pharmacy
|
July 9, 1985
Assessment of an adverse drug reaction monitoring program in nursing homes
J A Soon
Probe (Ottawa, Ont.)
|
January 1, 1992
Effects of drug therapy on oral health of older adults
J A Soon
Clinical Pharmacology and Therapeutics
|
November 29, 2007
Emergency contraception update: a Canadian perspective
V W Y Leung, J A Soon, M Levine
Canadian Pharmaceutical Journal
|
December 12, 1981
Drug usage review. Part three: implementing the long-term care program
D H Danforth, J N Hlynka, J A Soon
The Canadian Journal of Hospital Pharmacy
|
April 12, 1979
Adverse drug reactions: why should they be reported?
L K Golightly, D J Hall, G Kane, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 18, 2022
Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study
F Dimitriou, K Namikawa, I L M Reijers, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 7) with videos related to
Sort By:
Page
of 1
The Canadian Journal of Hospital Pharmacy
|
August 9, 1980
Developing an adverse drug reaction program in nursing homes
J A Soon
The Canadian Journal of Hospital Pharmacy
|
July 9, 1985
Assessment of an adverse drug reaction monitoring program in nursing homes
J A Soon
Probe (Ottawa, Ont.)
|
January 1, 1992
Effects of drug therapy on oral health of older adults
J A Soon
Clinical Pharmacology and Therapeutics
|
November 29, 2007
Emergency contraception update: a Canadian perspective
V W Y Leung, J A Soon, M Levine
Canadian Pharmaceutical Journal
|
December 12, 1981
Drug usage review. Part three: implementing the long-term care program
D H Danforth, J N Hlynka, J A Soon
The Canadian Journal of Hospital Pharmacy
|
April 12, 1979
Adverse drug reactions: why should they be reported?
L K Golightly, D J Hall, G Kane, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 18, 2022
Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study
F Dimitriou, K Namikawa, I L M Reijers, et al.
Page
of 1